Free Trial

Annovis Bio (ANVS) SEC Filings & 10K Form

Annovis Bio logo
$1.84 -0.01 (-0.54%)
Closing price 03/27/2025 03:58 PM Eastern
Extended Trading
$1.84 0.00 (0.00%)
As of 03/27/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Annovis Bio SEC Filings

DateFilerForm TypeView
03/27/2025
3:35 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
4:15 PM
Annovis Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2025
4:10 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
10:07 AM
Annovis Bio (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G
02/05/2025
7:08 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
5:01 AM
Annovis Bio (Filer)
Form 424B5
02/03/2025
5:00 AM
Annovis Bio (Filer)
Form 424B5
12/11/2024
3:25 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:07 AM
Annovis Bio (Filer)
Form 424B5
12/11/2024
5:10 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
4:08 PM
Annovis Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
7:12 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:38 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:15 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
7:05 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:05 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
4:15 PM
Annovis Bio (Issuer)
Bruck Claudine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:16 PM
Annovis Bio (Issuer)
Hoffman Michael B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:16 PM
Annovis Bio (Issuer)
Maccecchini Maria-Luisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:17 PM
Annovis Bio (Issuer)
McCarthy Reid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:18 PM
Annovis Bio (Issuer)
White Mark K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:14 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
4:15 PM
Annovis Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2024
5:05 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:32 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
4:11 PM
Annovis Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
4:18 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:50 PM
Annovis Bio (Filer)
Form 424B5
04/29/2024
4:14 PM
Annovis Bio (Filer)
Form ARS
04/26/2024
7:14 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:12 PM
Annovis Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:ANVS) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners